Navidea Biopharmaceuticals, Inc. | Ekinops

Navidea Biopharmaceuticals, Inc. | Ekinops

Author: Stock Day Media July 10, 2024 Duration: 0:54
Navidea Biopharmaceuticals, Inc. (OTC: NAVB), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced disappointing results of an exploratory analysis conducted on the company’s pivotal NAV3-33 clinical trial. Dr. Michael Blue, Navidea’s Chief Medical Officer, said "Results are not indicative of a commercially viable product.”

Ekinops (Euronext Paris: EKI) (ISIN: FR0011466069), a leading supplier of optical transport and enterprise connectivity solutions for telecom operators and enterprises, today announced that Orange Business has chosen Ekinops technology to launch its new SD-WAN offer named SD-WAN Essentials, transforming Enterprise connectivity into a stepping stone to the Cloud.

For more information, please visit StockDayMedia.com
Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

Tune into Stock Day Media for a direct line to the often-overlooked corners of the market. This podcast cuts through the noise of mainstream financial news to focus squarely on penny and micro-cap stocks, bringing clarity and opportunity to individual investors. Each episode is built on a mission of transparency, offering candid conversations with company executives and deep-dive analyses that you won't find elsewhere. The discussions here are practical and grounded, designed to inform your decisions by shedding light on the potential and the realities of these publicly traded companies. For anyone curious about unique investment avenues, this series connects you with emerging stories and lucrative possibilities before they hit the broader radar. Hosted by the team at Stock Day Media, the content leverages their deep reach within the investment community to source genuine insights. It’s more than just market updates; it’s about understanding the narratives and the numbers that drive smaller-cap ventures. If your interests lie in business news that goes beyond the headlines, this podcast serves as a dedicated resource for building knowledge and discovering what’s next.
Author: Language: English Episodes: 100

Stock Day Media
Podcast Episodes